EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE

EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE was reported 3566 times

EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 STOMACH SCAN ABNORMAL 5 0.1786
1 PARAPHIMOSIS 2 0.1053
2 HEPATOBILIARY PROCEDURAL COMPLICATION 2 0.0714
3 SYNOVIAL DISORDER 25 0.0549
4 INTESTINAL TRANSIT TIME ABNORMAL 2 0.0364
5 ALLERGIC SINUSITIS 26 0.0303
6 URINE KETONE BODY 4 0.0245
7 ANAL FUNGAL INFECTION 2 0.0241
8 BALANITIS CANDIDA 3 0.0234
9 EUGLYCAEMIC DIABETIC KETOACIDOSIS 87 0.0211
10 URINARY TRACT CANDIDIASIS 4 0.0209
11 FORCED EXPIRATORY FLOW DECREASED 2 0.0206
12 COMPLEMENT FACTOR C3 DECREASED 5 0.0205
13 PERINEAL INFECTION 4 0.0202
14 KETOACIDOSIS 129 0.0172
15 KETONURIA 14 0.0172
16 NEUROSURGERY 3 0.0162
17 URINE ALCOHOL TEST POSITIVE 3 0.0153
18 OLIGODIPSIA 3 0.0128
19 FOLLICULAR THYROID CANCER 2 0.0123
20 CHOLELITHIASIS OBSTRUCTIVE 2 0.0119
21 BLOOD GLUCOSE 2 0.0113
22 DIABETIC KETOACIDOTIC HYPERGLYCAEMIC COMA 2 0.0110
23 EMPHYSEMATOUS PYELONEPHRITIS 2 0.0109
24 COMPLEMENT FACTOR C4 DECREASED 2 0.0104
25 PENILE INFECTION 2 0.0103
26 Q FEVER 2 0.0094
27 GENITAL CANDIDIASIS 2 0.0094
28 ANORECTAL SWELLING 2 0.0087
29 VITAMIN B12 DECREASED 25 0.0087
30 TYPE IIA HYPERLIPIDAEMIA 2 0.0085
31 URETHRAL PAIN 5 0.0085
32 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 10 0.0083
33 PANCREATIC NEOPLASM 10 0.0081
34 SCROTAL ABSCESS 3 0.0079
35 DIABETIC KETOACIDOSIS 190 0.0079
36 ANTINUCLEAR ANTIBODY POSITIVE 25 0.0077
37 AUTONOMIC NEUROPATHY 7 0.0069
38 PERINEAL ABSCESS 3 0.0067
39 CATARRH 6 0.0066
40 URINARY TRACT DISCOMFORT 3 0.0065
41 FEAR OF EATING 2 0.0065
42 VAGINAL CANCER 2 0.0063
43 BALANOPOSTHITIS 5 0.0061
44 GENITAL INFECTION FUNGAL 5 0.0061
45 BLOOD KETONE BODY 2 0.0058
46 DIET REFUSAL 4 0.0055
47 PENILE ERYTHEMA 2 0.0053
48 URINARY TRACT INFECTION FUNGAL 3 0.0052
49 FEBRILE INFECTION 6 0.0051
50 ASYMPTOMATIC COVID-19 2 0.0051
51 BLOOD VISCOSITY INCREASED 3 0.0050
52 INSULIN RESISTANCE 10 0.0048
53 VAGINAL ULCERATION 2 0.0048
54 INCORRECT PRODUCT DOSAGE FORM ADMINISTERED 2 0.0048
55 KETOSIS 5 0.0046
56 GASTROINTESTINAL HYPOMOTILITY 10 0.0044
57 BLOOD URIC ACID INCREASED 25 0.0043
58 EATING DISORDER SYMPTOM 2 0.0043
59 PRURITUS GENITAL 10 0.0042
60 GLOMERULAR FILTRATION RATE ABNORMAL 6 0.0042
61 SHOCK HYPOGLYCAEMIC 2 0.0042
62 PERIPHERAL ARTERY STENOSIS 2 0.0042
63 DEBRIDEMENT 3 0.0039
64 ORTHOPAEDIC PROCEDURE 2 0.0039
65 JOINT EFFUSION 26 0.0038
66 GLYCOSYLATED HAEMOGLOBIN DECREASED 6 0.0037
67 TENOSYNOVITIS STENOSANS 2 0.0036
68 ENANTHEMA 2 0.0035
69 GENITAL BURNING SENSATION 3 0.0035
70 CHRONIC SPONTANEOUS URTICARIA 4 0.0034
71 AUTONOMIC NERVOUS SYSTEM IMBALANCE 10 0.0034
72 CANDIDA SEPSIS 3 0.0033
73 IMPAIRED GASTRIC EMPTYING 45 0.0033
74 DIABETIC FOOT 10 0.0033
75 EXCESSIVE CERUMEN PRODUCTION 2 0.0032
76 AMPUTATION 4 0.0032
77 GLYCOSYLATED HAEMOGLOBIN INCREASED 80 0.0032
78 URINE KETONE BODY PRESENT 5 0.0032
79 DRY GANGRENE 2 0.0031
80 PAROTID GLAND ENLARGEMENT 2 0.0031
81 FORCED VITAL CAPACITY DECREASED 2 0.0031
82 HIGH DENSITY LIPOPROTEIN INCREASED 3 0.0030
83 GENITAL SWELLING 2 0.0029
84 GENITAL PAIN 4 0.0027
85 CORTISOL DECREASED 3 0.0026
86 BLOOD KETONE BODY INCREASED 2 0.0026
87 LIMB MALFORMATION 2 0.0025
88 PENILE SWELLING 3 0.0024
89 PRODUCT RESIDUE PRESENT 13 0.0024
90 TOE AMPUTATION 12 0.0024
91 PAPILLARY THYROID CANCER 4 0.0023
92 EXTREMITY NECROSIS 4 0.0023
93 VULVOVAGINAL MYCOTIC INFECTION 9 0.0023
94 BLOOD IRON DECREASED 27 0.0023
95 BLOOD GLUCOSE ABNORMAL 42 0.0023
96 CYSTITIS HAEMORRHAGIC 9 0.0022
97 ADENOCARCINOMA GASTRIC 2 0.0022
98 SCROTAL SWELLING 2 0.0021
99 CYST 26 0.0021
100 FUNGAL INFECTION 69 0.0021
101 PANCREATIC ENZYMES INCREASED 3 0.0020
102 MASTOIDITIS 2 0.0020
103 MUCOSAL DISORDER 2 0.0020
104 PROSTATITIS 6 0.0020
105 POLYCYTHAEMIA 4 0.0019
106 PANCREATIC MASS 2 0.0019
107 NAIL DISCOLOURATION 7 0.0018
108 FOOD AVERSION 3 0.0018
109 CHEMICAL BURN 2 0.0017
110 BLOOD CHOLESTEROL ABNORMAL 8 0.0017
111 THYROIDECTOMY 3 0.0017
112 SPLENECTOMY 2 0.0017
113 SPINAL CORD INJURY 3 0.0017
114 RESTRICTIVE PULMONARY DISEASE 2 0.0017
115 NECROTISING FASCIITIS 6 0.0017
116 TENDONITIS 26 0.0017
117 INTRA-ABDOMINAL FLUID COLLECTION 3 0.0017
118 WEIGHT ABNORMAL 4 0.0017
119 PROSTATIC OPERATION 2 0.0017
120 POST-ACUTE COVID-19 SYNDROME 2 0.0016
121 LYMPH NODE PAIN 3 0.0016
122 LACTIC ACIDOSIS 52 0.0016
123 TESTICULAR PAIN 5 0.0016
124 BRONCHIAL SECRETION RETENTION 2 0.0016
125 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 2 0.0016
126 ADRENOCORTICAL INSUFFICIENCY ACUTE 3 0.0015
127 FOREIGN BODY IN RESPIRATORY TRACT 2 0.0015
128 GLYCOSURIA 2 0.0015
129 DIABETES MELLITUS INADEQUATE CONTROL 26 0.0015
130 GLOMERULAR FILTRATION RATE DECREASED 18 0.0015
131 LEG AMPUTATION 6 0.0015
132 DIABETIC METABOLIC DECOMPENSATION 2 0.0014
133 PERIPHERAL ARTERY THROMBOSIS 2 0.0014
134 PRERENAL FAILURE 2 0.0014
135 INJECTION SITE WARMTH 29 0.0014
136 INVESTIGATION ABNORMAL 2 0.0014
137 SYNOVITIS 25 0.0014
138 MYASTHENIA GRAVIS CRISIS 2 0.0013
139 GASTROINTESTINAL WALL THICKENING 2 0.0013
140 GANGRENE 8 0.0013
141 RENAL COLIC 3 0.0013
142 RESPIRATORY TRACT INFECTION VIRAL 3 0.0013
143 PANCREATITIS CHRONIC 3 0.0013
144 POLYDIPSIA 5 0.0013
145 BLOOD GLUCOSE INCREASED 238 0.0013
146 DIABETIC NEUROPATHY 6 0.0012
147 INFLAMMATORY MARKER INCREASED 6 0.0012
148 PROTEIN URINE PRESENT 6 0.0012
149 ERUCTATION 23 0.0012
150 VULVOVAGINAL PRURITUS 6 0.0012
151 TYMPANIC MEMBRANE PERFORATION 2 0.0012
152 ACIDOSIS 9 0.0012
153 DIABETIC RETINOPATHY 4 0.0012
154 MEAN CELL VOLUME INCREASED 3 0.0012
155 PHYSICAL DECONDITIONING 3 0.0012
156 PRODUCT CONTAINER SEAL ISSUE 2 0.0011
157 BLOOD GLUCOSE DECREASED 55 0.0011
158 ALOPECIA AREATA 2 0.0011
159 HYPERLACTACIDAEMIA 3 0.0011
160 SUSPECTED OFF LABEL USE 5 0.0011
161 MONOPARESIS 2 0.0011
162 ULCERATIVE KERATITIS 3 0.0011
163 METABOLIC ACIDOSIS 35 0.0011
164 BODY TEMPERATURE ABNORMAL 2 0.0011
165 UROSEPSIS 10 0.0011
166 INFECTED SKIN ULCER 2 0.0011
167 BLOOD BICARBONATE DECREASED 2 0.0011
168 PANCREATIC CYST 2 0.0010
169 CARDIAC OPERATION 9 0.0010
170 C-REACTIVE PROTEIN INCREASED 38 0.0010
171 FIBULA FRACTURE 3 0.0010
172 PATIENT DISSATISFACTION WITH TREATMENT 2 0.0010
173 OPTIC ISCHAEMIC NEUROPATHY 4 0.0010
174 GALLBLADDER INJURY 2 0.0010
175 PYELONEPHRITIS ACUTE 2 0.0010
176 PANCREATIC DISORDER 5 0.0010
177 DRUG DELIVERY SYSTEM ISSUE 2 0.0010
178 EYELID PAIN 2 0.0010
179 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 4 0.0010
180 CHANGE OF BOWEL HABIT 2 0.0010
181 MICROCYTIC ANAEMIA 2 0.0010
182 FOOD CRAVING 5 0.0009
183 BLOOD LACTIC ACID INCREASED 5 0.0009
184 EYE CONTUSION 2 0.0009
185 EAR SWELLING 2 0.0009
186 PARONYCHIA 4 0.0009
187 NOCTURIA 11 0.0009
188 NERVE INJURY 10 0.0009
189 TEMPERATURE REGULATION DISORDER 2 0.0009
190 FEAR OF DEATH 2 0.0009
191 ILEUS 11 0.0009
192 ABNORMAL LOSS OF WEIGHT 6 0.0009
193 HYPERGLYCAEMIA 32 0.0009
194 HAEMATOCRIT INCREASED 2 0.0009
195 HAEMOGLOBIN INCREASED 4 0.0009
196 BRAIN OPERATION 2 0.0009
197 REGURGITATION 3 0.0009
198 MICTURITION DISORDER 3 0.0009
199 POLLAKIURIA 36 0.0009
200 BLOOD POTASSIUM INCREASED 14 0.0009
201 SKIN WARM 5 0.0009
202 DISCOURAGEMENT 2 0.0009
203 SKIN ABRASION 4 0.0008
204 THIRST 15 0.0008
205 CARDIAC PACEMAKER INSERTION 5 0.0008
206 BLOOD GLUCOSE FLUCTUATION 9 0.0008
207 BREATH ODOUR 2 0.0008
208 INJECTION SITE INFLAMMATION 4 0.0008
209 PANCREATITIS ACUTE 18 0.0008
210 RENAL DISORDER 37 0.0008
211 TONGUE OEDEMA 3 0.0008
212 LIPASE INCREASED 6 0.0008
213 THYROID MASS 3 0.0008
214 DRUG TITRATION ERROR 2 0.0008
215 HYPERSENSITIVITY VASCULITIS 2 0.0008
216 APPETITE DISORDER 5 0.0008
217 TYPE IV HYPERSENSITIVITY REACTION 2 0.0007
218 PROSTATIC DISORDER 4 0.0007
219 ACUTE PULMONARY OEDEMA 4 0.0007
220 OSTEOARTHRITIS 30 0.0007
221 ESCHERICHIA URINARY TRACT INFECTION 3 0.0007
222 HYPOGLYCAEMIA 34 0.0007
223 TUMOUR HAEMORRHAGE 2 0.0007
224 DYSPNOEA AT REST 2 0.0007
225 THERAPEUTIC REACTION TIME DECREASED 2 0.0007
226 PANCREATITIS 36 0.0007
227 POOR VENOUS ACCESS 7 0.0007
228 NEPHROLITHIASIS 31 0.0007
229 CARDIOTOXICITY 6 0.0007
230 ILEUS PARALYTIC 3 0.0007
231 BLOOD CULTURE POSITIVE 2 0.0007
232 HYDRONEPHROSIS 5 0.0007
233 THYROIDITIS 2 0.0007
234 NORMOCHROMIC NORMOCYTIC ANAEMIA 2 0.0007
235 HYPOPHAGIA 17 0.0007
236 RENAL PAIN 7 0.0007
237 WEIGHT DECREASED 184 0.0007
238 RECTAL CANCER 2 0.0007
239 NERVE COMPRESSION 6 0.0006
240 DIASTOLIC DYSFUNCTION 2 0.0006
241 ATRIOVENTRICULAR BLOCK 5 0.0006
242 EXTRA DOSE ADMINISTERED 26 0.0006
243 INJECTION SITE HYPERSENSITIVITY 2 0.0006
244 FOREIGN BODY IN THROAT 2 0.0006
245 PROCTALGIA 4 0.0006
246 POSTURE ABNORMAL 2 0.0006
247 BACTERIAL SEPSIS 2 0.0006
248 POLYURIA 5 0.0006
249 HYPERNATRAEMIA 3 0.0006
250 PROSTATE CANCER METASTATIC 2 0.0006
251 PRODUCT DISPENSING ERROR 13 0.0006
252 SEPSIS 66 0.0006
253 B-CELL LYMPHOMA 2 0.0006
254 TACHYPNOEA 8 0.0006
255 ERECTILE DYSFUNCTION 15 0.0006
256 INTERNATIONAL NORMALISED RATIO ABNORMAL 2 0.0006
257 MYOPATHY 5 0.0006
258 HYPOPNOEA 2 0.0006
259 CAROTID ARTERY STENOSIS 2 0.0006
260 EAR PRURITUS 2 0.0006
261 URINARY RETENTION 19 0.0006
262 ARTHROPATHY 31 0.0006
263 OEDEMA 30 0.0006
264 DERMATITIS BULLOUS 4 0.0006
265 FAECES SOFT 4 0.0005
266 URINARY TRACT INFECTION 93 0.0005
267 AMYLASE INCREASED 2 0.0005
268 PHOTOPHOBIA 10 0.0005
269 PEMPHIGOID 4 0.0005
270 FLATULENCE 30 0.0005
271 HEPATIC ENZYME INCREASED 36 0.0005
272 TROPONIN INCREASED 4 0.0005
273 PARANASAL SINUS HYPERSECRETION 2 0.0005
274 BOWEL MOVEMENT IRREGULARITY 4 0.0005
275 HERPES VIRUS INFECTION 3 0.0005
276 SINUS CONGESTION 7 0.0005
277 HYPERVENTILATION 3 0.0005
278 METABOLIC DISORDER 3 0.0005
279 ELECTROLYTE IMBALANCE 6 0.0005
280 LIMB INJURY 14 0.0005
281 FAECES HARD 2 0.0005
282 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 24 0.0005
283 HYPOVOLAEMIA 3 0.0005
284 DEHYDRATION 68 0.0005
285 PRODUCT ADMINISTRATION INTERRUPTED 4 0.0005
286 PROSTATOMEGALY 2 0.0005
287 DECREASED INTEREST 3 0.0005
288 SKIN ODOUR ABNORMAL 2 0.0005
289 LABORATORY TEST ABNORMAL 15 0.0005
290 COVID-19 PNEUMONIA 6 0.0005
291 PROSTATIC SPECIFIC ANTIGEN INCREASED 7 0.0005
292 LIGAMENT SPRAIN 5 0.0005
293 PRODUCT PRESCRIBING ERROR 12 0.0005
294 HYPERPHAGIA 2 0.0005
295 OSTEOMYELITIS 9 0.0005
296 INJECTION SITE VESICLES 3 0.0005
297 RECURRENT CANCER 2 0.0005
298 PERIPHERAL ISCHAEMIA 2 0.0005
299 TRIGGER FINGER 2 0.0005
300 DYSURIA 18 0.0005
301 ALANINE AMINOTRANSFERASE INCREASED 30 0.0005
302 ANAPHYLACTOID REACTION 2 0.0005
303 PIGMENTATION DISORDER 3 0.0005
304 HYPERKALAEMIA 17 0.0005
305 BACTERIAL INFECTION 9 0.0005
306 GASTROENTERITIS 7 0.0005
307 WEIGHT FLUCTUATION 5 0.0005
308 THROAT CANCER 2 0.0005
309 POOR PERIPHERAL CIRCULATION 2 0.0005
310 PRODUCT DISPENSING ISSUE 2 0.0005
311 STAPHYLOCOCCAL BACTERAEMIA 2 0.0005
312 DIVERTICULUM INTESTINAL 2 0.0005
313 DYSPHEMIA 2 0.0005
314 ARTERIOSCLEROSIS CORONARY ARTERY 3 0.0005
315 INTESTINAL OBSTRUCTION 17 0.0005
316 VOMITING 212 0.0005
317 ACUTE KIDNEY INJURY 69 0.0005
318 RHINITIS ALLERGIC 2 0.0004
319 LOSS OF LIBIDO 4 0.0004
320 URINE ABNORMALITY 2 0.0004
321 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
322 ABSCESS 7 0.0004
323 DISEASE COMPLICATION 2 0.0004
324 EYE OPERATION 2 0.0004
325 DIABETES MELLITUS 33 0.0004
326 HYPERTRANSAMINASAEMIA 3 0.0004
327 CONSTIPATION 94 0.0004
328 VAGINAL INFECTION 2 0.0004
329 PRODUCT DOSE OMISSION IN ERROR 12 0.0004
330 EATING DISORDER 9 0.0004
331 FOOT FRACTURE 8 0.0004
332 CHOLECYSTITIS 5 0.0004
333 SLEEP APNOEA SYNDROME 8 0.0004
334 SUBDURAL HAEMATOMA 6 0.0004
335 LIMB OPERATION 2 0.0004
336 INTENTIONAL UNDERDOSE 3 0.0004
337 INCORRECT DOSAGE ADMINISTERED 2 0.0004
338 BLINDNESS TRANSIENT 3 0.0004
339 PSYCHIATRIC SYMPTOM 3 0.0004
340 DECREASED APPETITE 94 0.0004
341 FOOT OPERATION 2 0.0004
342 BRAIN INJURY 4 0.0004
343 ABDOMINAL PAIN UPPER 82 0.0004
344 VAGINAL DISCHARGE 4 0.0004
345 MUSCLE ATROPHY 5 0.0004
346 ARTHRITIS 31 0.0004
347 DYSLIPIDAEMIA 2 0.0004
348 GOUT 7 0.0004
349 ROTATOR CUFF SYNDROME 5 0.0004
350 INTENTIONAL PRODUCT USE ISSUE 34 0.0004
351 PERIORBITAL OEDEMA 2 0.0004
352 TORSADE DE POINTES 3 0.0004
353 PRODUCT ODOUR ABNORMAL 4 0.0004
354 INJECTION SITE MASS 14 0.0004
355 ULCER 6 0.0004
356 ATRIAL FLUTTER 3 0.0004
357 HEREDITARY ANGIOEDEMA 4 0.0004
358 STENT PLACEMENT 3 0.0004
359 POOR QUALITY SLEEP 8 0.0004
360 ANAL ABSCESS 2 0.0004
361 HIP SURGERY 2 0.0004
362 BACK DISORDER 6 0.0004
363 HYPOKALAEMIA 17 0.0004
364 DECUBITUS ULCER 3 0.0004
365 INCREASED APPETITE 7 0.0004
366 COVID-19 64 0.0004
367 DEAFNESS UNILATERAL 2 0.0004
368 VENTRICULAR FIBRILLATION 4 0.0004
369 EOSINOPHIL COUNT INCREASED 3 0.0004
370 HYPOMAGNESAEMIA 5 0.0004
371 CHOKING 7 0.0004
372 MASS 5 0.0004
373 MACULAR OEDEMA 2 0.0004
374 CANDIDA INFECTION 6 0.0004
375 COLECTOMY 2 0.0004
376 BLOOD PRESSURE ABNORMAL 7 0.0004
377 ANURIA 3 0.0003
378 BLOOD MAGNESIUM DECREASED 3 0.0003
379 EXERCISE TOLERANCE DECREASED 2 0.0003
380 PYELONEPHRITIS 3 0.0003
381 DEVICE DEFECTIVE 6 0.0003
382 SKIN SWELLING 3 0.0003
383 PSORIASIS 45 0.0003
384 RESPIRATORY SYNCYTIAL VIRUS INFECTION 3 0.0003
385 RALES 2 0.0003
386 SPINAL PAIN 4 0.0003
387 BLOOD TRIGLYCERIDES INCREASED 6 0.0003
388 ENERGY INCREASED 2 0.0003
389 ODYNOPHAGIA 2 0.0003
390 LOCALISED INFECTION 8 0.0003
391 OPTIC NEURITIS 3 0.0003
392 INSURANCE ISSUE 5 0.0003
393 MENISCUS INJURY 2 0.0003
394 IRON DEFICIENCY ANAEMIA 3 0.0003
395 DIVERTICULITIS 9 0.0003
396 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
397 ALTERED STATE OF CONSCIOUSNESS 7 0.0003
398 GASTROOESOPHAGEAL REFLUX DISEASE 26 0.0003
399 BLOOD CREATININE INCREASED 21 0.0003
400 INFUSION SITE EXTRAVASATION 2 0.0003
401 DEFORMITY 3 0.0003
402 AGEUSIA 8 0.0003
403 PRE-EXISTING CONDITION IMPROVED 2 0.0003
404 SWELLING OF EYELID 2 0.0003
405 INFUSION RELATED REACTION 21 0.0003
406 BLOOD URINE PRESENT 6 0.0003
407 ABDOMINAL DISCOMFORT 53 0.0003
408 GAMMA-GLUTAMYLTRANSFERASE INCREASED 7 0.0003
409 NAUSEA 249 0.0003
410 RECALLED PRODUCT ADMINISTERED 3 0.0003
411 ENTERITIS 2 0.0003
412 INCORRECT DOSE ADMINISTERED 71 0.0003
413 HAEMOGLOBIN ABNORMAL 2 0.0003
414 ILLNESS 32 0.0003
415 CARDIAC FLUTTER 2 0.0003
416 JOINT SWELLING 37 0.0003
417 BRADYPHRENIA 2 0.0003
418 INCORRECT DOSE ADMINISTERED BY DEVICE 8 0.0003
419 JOINT STIFFNESS 8 0.0003
420 DISABILITY 6 0.0003
421 PULMONARY CONGESTION 4 0.0003
422 SARS-COV-2 TEST POSITIVE 4 0.0003
423 CORONAVIRUS INFECTION 2 0.0003
424 INABILITY TO AFFORD MEDICATION 3 0.0003
425 SKIN MASS 2 0.0003
426 MENINGITIS 2 0.0003
427 POST-TRAUMATIC STRESS DISORDER 2 0.0003
428 EMPHYSEMA 3 0.0003
429 BRONCHIECTASIS 2 0.0003
430 METASTASES TO LYMPH NODES 2 0.0003
431 TASTE DISORDER 6 0.0003
432 NEUTROPHIL COUNT INCREASED 3 0.0003
433 DIZZINESS 146 0.0003
434 INITIAL INSOMNIA 3 0.0003
435 ABDOMINAL PAIN 68 0.0003
436 AMNESIA 19 0.0003
437 CORONARY ARTERY OCCLUSION 4 0.0003
438 GASTRIC DISORDER 10 0.0003
439 PERIPHERAL COLDNESS 4 0.0003
440 ONYCHOCLASIS 2 0.0003
441 MUSCULOSKELETAL DISCOMFORT 5 0.0003
442 LARGE INTESTINE POLYP 2 0.0003
443 AUTOIMMUNE HEPATITIS 2 0.0003
444 DIARRHOEA 185 0.0003
445 EXTRASYSTOLES 2 0.0003
446 DEFAECATION URGENCY 2 0.0003
447 INJECTION SITE DISCOMFORT 3 0.0003
448 COLD SWEAT 5 0.0003
449 DUODENAL ULCER 2 0.0003
450 SEASONAL ALLERGY 4 0.0003
451 DIVERTICULUM 2 0.0003
452 RETCHING 6 0.0003
453 ACCIDENTAL UNDERDOSE 4 0.0003
454 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 50 0.0003
455 PANCREATIC CARCINOMA 8 0.0003
456 FAECES DISCOLOURED 6 0.0003
457 DEVICE LEAKAGE 12 0.0003
458 SKIN LACERATION 3 0.0003
459 DYSPEPSIA 27 0.0003
460 RENAL IMPAIRMENT 23 0.0003
461 CHEST DISCOMFORT 28 0.0003
462 ACCIDENTAL OVERDOSE 10 0.0003
463 INJECTION SITE NODULE 3 0.0003
464 NASAL CONGESTION 16 0.0003
465 ACUTE MYOCARDIAL INFARCTION 8 0.0003
466 ASTHENIA 102 0.0003
467 SKIN ULCER 7 0.0003
468 FOOT DEFORMITY 3 0.0003
469 ARTHROPOD BITE 2 0.0003
470 HYPERTENSIVE CRISIS 3 0.0003
471 GAIT INABILITY 9 0.0003
472 FEELING DRUNK 2 0.0003
473 PRODUCT DOSE OMISSION ISSUE 79 0.0003
474 MALNUTRITION 3 0.0003
475 NERVOUSNESS 14 0.0003
476 MIDDLE INSOMNIA 5 0.0003
477 BLOOD CALCIUM DECREASED 3 0.0003
478 BLOOD POTASSIUM DECREASED 8 0.0003
479 HYPOCALCAEMIA 5 0.0003
480 HAEMODYNAMIC INSTABILITY 2 0.0003
481 LYMPHOMA 4 0.0003
482 ABDOMINAL DISTENSION 27 0.0003
483 HERNIA 5 0.0003
484 CONCUSSION 2 0.0003
485 APHTHOUS ULCER 2 0.0003
486 BLOOD PRESSURE DECREASED 17 0.0003
487 MULTIPLE ALLERGIES 2 0.0003
488 ARTERIAL OCCLUSIVE DISEASE 2 0.0003
489 SEPTIC SHOCK 11 0.0003
490 BACTERAEMIA 3 0.0003
491 RENAL CYST 2 0.0003
492 HYPERLIPIDAEMIA 3 0.0003
493 SCIATICA 4 0.0003
494 HIP FRACTURE 8 0.0002
495 NIGHT SWEATS 8 0.0002
496 PAIN IN EXTREMITY 73 0.0002
497 MYASTHENIA GRAVIS 2 0.0002
498 FRUSTRATION TOLERANCE DECREASED 2 0.0002
499 POST PROCEDURAL INFECTION 2 0.0002
500 DISCOMFORT 15 0.0002
501 BLINDNESS 10 0.0002
502 INJECTION SITE URTICARIA 6 0.0002
503 ANGINA PECTORIS 7 0.0002
504 ABNORMAL FAECES 2 0.0002
505 HICCUPS 2 0.0002
506 SPINAL OPERATION 3 0.0002
507 ESCHERICHIA INFECTION 2 0.0002
508 INJECTION SITE DISCOLOURATION 3 0.0002
509 PEMPHIGUS 3 0.0002
510 INTENTIONAL PRODUCT MISUSE 21 0.0002
511 RHABDOMYOLYSIS 10 0.0002
512 TYPE 2 DIABETES MELLITUS 8 0.0002
513 SENSATION OF FOREIGN BODY 2 0.0002
514 INFUSION SITE ERYTHEMA 2 0.0002
515 FACE OEDEMA 4 0.0002
516 HALLUCINATION, VISUAL 5 0.0002
517 URINARY INCONTINENCE 7 0.0002
518 FACIAL PARALYSIS 2 0.0002
519 GASTROINTESTINAL DISORDER 21 0.0002
520 JOINT INJURY 5 0.0002
521 SCAR 4 0.0002
522 HAEMATURIA 8 0.0002
523 DRUG INTERACTION 37 0.0002
524 PSYCHOLOGICAL TRAUMA 2 0.0002
525 INJECTION SITE INDURATION 3 0.0002
526 CARDIAC MURMUR 2 0.0002
527 HYPOTENSION 46 0.0002
528 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 11 0.0002
529 URINE OUTPUT DECREASED 2 0.0002
530 MUSCULOSKELETAL STIFFNESS 20 0.0002
531 INJECTION SITE PAIN 70 0.0002
532 BURNING SENSATION 16 0.0002
533 BLOOD CALCIUM INCREASED 2 0.0002
534 GROIN PAIN 2 0.0002
535 ANKYLOSING SPONDYLITIS 3 0.0002
536 LIMB DISCOMFORT 7 0.0002
537 PURPURA 2 0.0002
538 HEAD DISCOMFORT 4 0.0002
539 RESPIRATORY RATE INCREASED 2 0.0002
540 EYE HAEMORRHAGE 3 0.0002
541 NEOPLASM MALIGNANT 15 0.0002
542 THERAPY INTERRUPTED 16 0.0002
543 JOINT RANGE OF MOTION DECREASED 3 0.0002
544 GASTROINTESTINAL INFECTION 2 0.0002
545 MYOSITIS 2 0.0002
546 ELECTROCARDIOGRAM QT PROLONGED 8 0.0002
547 FREQUENT BOWEL MOVEMENTS 6 0.0002
548 DRY MOUTH 18 0.0002
549 SURGERY 13 0.0002
550 PSORIATIC ARTHROPATHY 9 0.0002
551 OROPHARYNGEAL DISCOMFORT 2 0.0002
552 HEAD INJURY 7 0.0002
553 PERIPHERAL SWELLING 34 0.0002
554 DRY EYE 11 0.0002
555 MUSCULAR WEAKNESS 25 0.0002
556 RESTLESS LEGS SYNDROME 4 0.0002
557 DEVICE DELIVERY SYSTEM ISSUE 6 0.0002
558 EXOSTOSIS 2 0.0002
559 VISUAL IMPAIRMENT 27 0.0002
560 BRAIN NEOPLASM 2 0.0002
561 RETINAL DETACHMENT 2 0.0002
562 HUNGER 3 0.0002
563 DEMENTIA 6 0.0002
564 HEPATIC ENCEPHALOPATHY 2 0.0002
565 CARPAL TUNNEL SYNDROME 3 0.0002
566 ARTHRALGIA 89 0.0002
567 HEPATIC CIRRHOSIS 4 0.0002
568 BLINDNESS UNILATERAL 3 0.0002
569 ARTERIOSCLEROSIS 2 0.0002
570 HOT FLUSH 16 0.0002
571 BLOOD SODIUM DECREASED 4 0.0002
572 LEUKAEMIA 2 0.0002
573 SPINAL DISORDER 2 0.0002
574 MEMORY IMPAIRMENT 29 0.0002
575 DYSPHAGIA 20 0.0002
576 FALL 70 0.0002
577 BRONCHOSPASM 3 0.0002
578 DISEASE RECURRENCE 10 0.0002
579 HYPOACUSIS 9 0.0002
580 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
581 IMPAIRED QUALITY OF LIFE 3 0.0002
582 POST PROCEDURAL COMPLICATION 4 0.0002
583 NEURALGIA 5 0.0002
584 DYSSTASIA 6 0.0002
585 TREMOR 34 0.0002
586 SKIN FISSURES 4 0.0002
587 THERAPY CHANGE 2 0.0002
588 KNEE OPERATION 2 0.0002
589 LOSS OF CONSCIOUSNESS 26 0.0002
590 HOSPICE CARE 2 0.0002
591 SKIN HAEMORRHAGE 3 0.0002
592 HYPERHIDROSIS 26 0.0002
593 CEREBROVASCULAR ACCIDENT 34 0.0002
594 PRESCRIBED UNDERDOSE 4 0.0002
595 INJECTION SITE HAEMORRHAGE 16 0.0002
596 PYREXIA 69 0.0002
597 SLEEP DISORDER 14 0.0002
598 ECONOMIC PROBLEM 3 0.0002
599 MEDICATION ERROR 11 0.0002
600 RASH 86 0.0002
601 FEEDING DISORDER 4 0.0002
602 SUBARACHNOID HAEMORRHAGE 2 0.0002
603 SKIN DISCOLOURATION 9 0.0002
604 DEVICE RELATED INFECTION 3 0.0002
605 CHEST PAIN 36 0.0002
606 ANKLE FRACTURE 3 0.0002
607 BLOOD CHOLESTEROL INCREASED 9 0.0002
608 BASAL CELL CARCINOMA 3 0.0002
609 NERVOUS SYSTEM DISORDER 6 0.0002
610 WEIGHT INCREASED 43 0.0002
611 TENDERNESS 2 0.0002
612 BRAIN FOG 3 0.0002
613 DERMATITIS 4 0.0002
614 TRANSFUSION 2 0.0002
615 PRODUCT USE COMPLAINT 3 0.0002
616 ANHEDONIA 5 0.0002
617 FATIGUE 148 0.0002
618 MOUTH ULCERATION 4 0.0002
619 DEVICE ISSUE 17 0.0002
620 BACK PAIN 44 0.0002
621 NEUROPATHY PERIPHERAL 18 0.0002
622 INCONTINENCE 2 0.0002
623 JOINT DISLOCATION 2 0.0002
624 EAR INFECTION 5 0.0002
625 FEAR 5 0.0002
626 RHINORRHOEA 12 0.0002
627 MUSCLE TIGHTNESS 3 0.0002
628 CATARACT 11 0.0002
629 INCORRECT PRODUCT ADMINISTRATION DURATION 4 0.0002
630 RASH PRURITIC 10 0.0002
631 BIPOLAR DISORDER 2 0.0002
632 MYOCARDIAL INFARCTION 32 0.0002
633 PULMONARY THROMBOSIS 2 0.0002
634 OESOPHAGITIS 2 0.0002
635 CHOLELITHIASIS 6 0.0002
636 TREATMENT NONCOMPLIANCE 10 0.0002
637 ASPIRATION 2 0.0002
638 HEART RATE INCREASED 18 0.0002
639 ANAPHYLACTIC REACTION 10 0.0002
640 MENTAL STATUS CHANGES 5 0.0002
641 TRANSAMINASES INCREASED 4 0.0002
642 OBSTRUCTIVE AIRWAYS DISORDER 2 0.0002
643 HAEMOPTYSIS 5 0.0002
644 ORAL PAIN 4 0.0002
645 SNEEZING 4 0.0002
646 THERAPEUTIC RESPONSE UNEXPECTED 8 0.0002
647 RESPIRATORY FAILURE 13 0.0002
648 OCULAR DISCOMFORT 2 0.0002
649 CONDITION AGGRAVATED 54 0.0002
650 STATUS EPILEPTICUS 2 0.0002
651 REBOUND EFFECT 2 0.0002
652 MYALGIA 30 0.0002
653 BRONCHITIS 13 0.0002
654 DERMATITIS CONTACT 2 0.0002
655 MYOCARDITIS 2 0.0002
656 PAIN 107 0.0002
657 SHOCK 4 0.0002
658 LETHARGY 10 0.0002
659 SEIZURE 20 0.0002
660 METASTASES TO LUNG 2 0.0002
661 PERICARDIAL EFFUSION 4 0.0002
662 OROPHARYNGEAL PAIN 16 0.0002
663 MADAROSIS 2 0.0002
664 EOSINOPHILIA 3 0.0002
665 SEXUAL DYSFUNCTION 2 0.0002
666 INFLUENZA 19 0.0002
667 SOMNOLENCE 34 0.0002
668 ISCHAEMIC STROKE 3 0.0002
669 GALLBLADDER DISORDER 3 0.0002
670 COMA 8 0.0002
671 PRODUCTIVE COUGH 8 0.0002
672 MACULAR DEGENERATION 2 0.0002
673 POLYNEUROPATHY 2 0.0002
674 BLOOD PRESSURE FLUCTUATION 4 0.0002
675 MALAISE 73 0.0002
676 SINUSITIS 17 0.0002
677 APHASIA 5 0.0002
678 LACRIMATION INCREASED 5 0.0002
679 PARAESTHESIA 26 0.0002
680 HYPERTENSION 35 0.0002
681 BONE DISORDER 3 0.0002
682 SCHIZOPHRENIA 2 0.0002
683 INJECTION SITE RASH 5 0.0002
684 INJECTION SITE BRUISING 13 0.0002
685 RECTAL HAEMORRHAGE 7 0.0002
686 MUSCLE SPASTICITY 2 0.0002
687 SMALL INTESTINAL OBSTRUCTION 2 0.0002
688 INJECTION SITE EXTRAVASATION 2 0.0002
689 CARDIAC FAILURE 13 0.0002
690 CONFUSIONAL STATE 26 0.0002
691 HYPOAESTHESIA 24 0.0002
692 CARDIAC DISORDER 15 0.0002
693 SECRETION DISCHARGE 2 0.0002
694 DERMATITIS ALLERGIC 2 0.0002
695 RENAL FAILURE 21 0.0002
696 PROTEINURIA 3 0.0002
697 MUSCULOSKELETAL DISORDER 3 0.0002
698 INJECTION SITE IRRITATION 2 0.0002
699 CYSTITIS 5 0.0002
700 BLOOD PRESSURE INCREASED 24 0.0002
701 HEPATITIS 4 0.0002
702 CHOLESTASIS 3 0.0002
703 LOWER LIMB FRACTURE 3 0.0002
704 THROAT IRRITATION 7 0.0002
705 ACUTE RESPIRATORY FAILURE 3 0.0002
706 INTENTIONAL OVERDOSE 10 0.0002
707 GLAUCOMA 3 0.0002
708 MOVEMENT DISORDER 5 0.0002
709 ANAPHYLACTIC SHOCK 4 0.0002
710 PRESCRIBED OVERDOSE 3 0.0002
711 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 11 0.0002
712 HAEMORRHOIDS 3 0.0002
713 NODULE 2 0.0002
714 KIDNEY INFECTION 3 0.0002
715 ECZEMA 8 0.0002
716 SEDATION 4 0.0002
717 IMPAIRED HEALING 5 0.0002
718 BEDRIDDEN 2 0.0002
719 GASTRITIS 4 0.0002
720 DEPRESSED LEVEL OF CONSCIOUSNESS 6 0.0002
721 DISORIENTATION 6 0.0002
722 DEPRESSED MOOD 8 0.0002
723 SOPOR 2 0.0002
724 UPPER LIMB FRACTURE 3 0.0002
725 EXPIRED PRODUCT ADMINISTERED 5 0.0002
726 FEELING ABNORMAL 36 0.0002
727 PLATELET COUNT DECREASED 16 0.0001
728 INJECTION SITE PRURITUS 10 0.0001
729 JAUNDICE 4 0.0001
730 PRODUCT ADMINISTRATION ERROR 3 0.0001
731 DISTURBANCE IN ATTENTION 8 0.0001
732 HEADACHE 93 0.0001
733 TRANSIENT ISCHAEMIC ATTACK 5 0.0001
734 DYSGEUSIA 11 0.0001
735 PRODUCT TASTE ABNORMAL 2 0.0001
736 UVEITIS 2 0.0001
737 RASH ERYTHEMATOUS 7 0.0001
738 OFF LABEL USE 128 0.0001
739 DEVICE MECHANICAL ISSUE 2 0.0001
740 RIB FRACTURE 3 0.0001
741 VISION BLURRED 20 0.0001
742 ORAL DISCOMFORT 2 0.0001
743 PRURITUS 55 0.0001
744 INSOMNIA 38 0.0001
745 HEART RATE DECREASED 5 0.0001
746 OXYGEN SATURATION DECREASED 8 0.0001
747 EYE PAIN 8 0.0001
748 MULTIPLE ORGAN DYSFUNCTION SYNDROME 4 0.0001
749 NASOPHARYNGITIS 26 0.0001
750 DIALYSIS 2 0.0001
751 SINUS TACHYCARDIA 2 0.0001
752 LEUKOPENIA 7 0.0001
753 LIVER FUNCTION TEST INCREASED 3 0.0001
754 CARDIOGENIC SHOCK 2 0.0001
755 CELLULITIS 7 0.0001
756 BALANCE DISORDER 12 0.0001
757 PRURITUS GENERALISED 3 0.0001
758 PARAESTHESIA ORAL 2 0.0001
759 ANOSMIA 2 0.0001
760 HYPERTHYROIDISM 2 0.0001
761 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
762 PRODUCT PRESCRIBING ISSUE 3 0.0001
763 APATHY 2 0.0001
764 CARDIAC FAILURE CONGESTIVE 11 0.0001
765 PALPITATIONS 16 0.0001
766 THERAPY CESSATION 7 0.0001
767 ANGIOEDEMA 6 0.0001
768 LIVER DISORDER 6 0.0001
769 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
770 RASH MACULO-PAPULAR 3 0.0001
771 PULMONARY MASS 2 0.0001
772 CHROMATURIA 3 0.0001
773 HEART RATE IRREGULAR 3 0.0001
774 CORONARY ARTERY DISEASE 4 0.0001
775 DEVICE FAILURE 2 0.0001
776 MUSCLE SPASMS 24 0.0001
777 HIP ARTHROPLASTY 2 0.0001
778 FEELING HOT 8 0.0001
779 SKIN EXFOLIATION 11 0.0001
780 FEMUR FRACTURE 4 0.0001
781 DELUSION 2 0.0001
782 EJECTION FRACTION DECREASED 2 0.0001
783 DYSPNOEA 72 0.0001
784 CYANOSIS 2 0.0001
785 ARRHYTHMIA 6 0.0001
786 RESPIRATORY TRACT CONGESTION 2 0.0001
787 OBESITY 2 0.0001
788 GAIT DISTURBANCE 24 0.0001
789 MOBILITY DECREASED 9 0.0001
790 HYPOTHYROIDISM 4 0.0001
791 HYPONATRAEMIA 7 0.0001
792 TACHYCARDIA 11 0.0001
793 MENTAL IMPAIRMENT 3 0.0001
794 PNEUMONIA 40 0.0001
795 OEDEMA PERIPHERAL 15 0.0001
796 SWELLING FACE 8 0.0001
797 ENCEPHALOPATHY 3 0.0001
798 PRODUCT SUBSTITUTION ISSUE 7 0.0001
799 STAPHYLOCOCCAL INFECTION 4 0.0001
800 CARDIAC ARREST 10 0.0001
801 LIP SWELLING 4 0.0001
802 DYSPHONIA 7 0.0001
803 ROAD TRAFFIC ACCIDENT 5 0.0001
804 BLOOD UREA INCREASED 2 0.0001
805 ABDOMINAL PAIN LOWER 3 0.0001
806 CHRONIC KIDNEY DISEASE 9 0.0001
807 HAEMATEMESIS 3 0.0001
808 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 2 0.0001
809 INFECTION 17 0.0001
810 IRRITABILITY 7 0.0001
811 EXPOSURE VIA SKIN CONTACT 3 0.0001
812 DIPLOPIA 3 0.0001
813 RESPIRATORY TRACT INFECTION 3 0.0001
814 ASTHMA 13 0.0001
815 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 6 0.0001
816 RASH MACULAR 4 0.0001
817 DEVICE USE ISSUE 2 0.0001
818 DEPRESSION 26 0.0001
819 COUGH 32 0.0001
820 METASTASES TO LIVER 2 0.0001
821 DERMATITIS ATOPIC 6 0.0001
822 HYPOXIA 4 0.0001
823 ATRIAL FIBRILLATION 11 0.0001
824 DRUG ERUPTION 2 0.0001
825 GENERAL PHYSICAL HEALTH DETERIORATION 13 0.0001
826 CEREBRAL HAEMORRHAGE 4 0.0001
827 PULMONARY OEDEMA 5 0.0001
828 THROAT TIGHTNESS 3 0.0001
829 CHILLS 13 0.0001
830 DRUG INEFFECTIVE 146 0.0001
831 GASTROENTERITIS VIRAL 2 0.0001
832 LEUKOCYTOSIS 2 0.0001
833 PALLOR 3 0.0001
834 PNEUMONITIS 3 0.0001
835 END STAGE RENAL DISEASE 2 0.0001
836 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 2 0.0001
837 TINNITUS 5 0.0001
838 PROCEDURAL PAIN 3 0.0001
839 DEEP VEIN THROMBOSIS 7 0.0001
840 HEPATIC STEATOSIS 2 0.0001
841 PANCYTOPENIA 6 0.0001
842 THINKING ABNORMAL 2 0.0001
843 FRACTURE 2 0.0001
844 COLITIS 4 0.0001
845 OCULAR HYPERAEMIA 5 0.0001
846 DRY SKIN 14 0.0001
847 INJECTION SITE ERYTHEMA 13 0.0001
848 HYPERSOMNIA 3 0.0001
849 HERPES ZOSTER 6 0.0001
850 INJECTION SITE SWELLING 8 0.0001
851 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
852 DRUG INTOLERANCE 10 0.0001
853 PRODUCT QUALITY ISSUE 14 0.0001
854 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
855 ALOPECIA 20 0.0001
856 INJECTION SITE REACTION 7 0.0001
857 PSYCHOTIC DISORDER 3 0.0001
858 PRODUCT USE ISSUE 19 0.0001
859 SINUS DISORDER 2 0.0001
860 SYNCOPE 10 0.0001
861 HEPATIC FAILURE 3 0.0001
862 FULL BLOOD COUNT DECREASED 2 0.0001
863 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
864 ILL-DEFINED DISORDER 6 0.0001
865 PLEURAL EFFUSION 6 0.0001
866 VERTIGO 6 0.0001
867 DYSKINESIA 4 0.0001
868 BODY TEMPERATURE INCREASED 2 0.0001
869 INFLAMMATION 5 0.0001
870 SWELLING 9 0.0001
871 KNEE ARTHROPLASTY 2 0.0001
872 ASPARTATE AMINOTRANSFERASE INCREASED 5 0.0001
873 IMPAIRED WORK ABILITY 2 0.0001
874 CONTUSION 9 0.0001
875 MENTAL DISORDER 4 0.0001
876 ANXIETY 26 0.0001
877 EYE DISORDER 3 0.0001
878 MELAENA 2 0.0001
879 THERAPEUTIC RESPONSE SHORTENED 3 0.0001
880 VISUAL ACUITY REDUCED 3 0.0001
881 VIRAL INFECTION 3 0.0001
882 STEVENS-JOHNSON SYNDROME 2 0.0001
883 URTICARIA 15 0.0001
884 NECK PAIN 5 0.0001
885 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 18 0.0001
886 PRODUCT AVAILABILITY ISSUE 2 0.0001
887 NIGHTMARE 3 0.0001
888 UPPER RESPIRATORY TRACT INFECTION 4 0.0001
889 DEVICE USE ERROR 3 0.0001
890 BONE PAIN 5 0.0001
891 INFLUENZA LIKE ILLNESS 7 0.0001
892 BLADDER CANCER 5 0.0001
893 HOSPITALISATION 13 0.0001
894 ANAEMIA 16 0.0001
895 HEPATIC CANCER 2 0.0001
896 SUICIDE ATTEMPT 5 0.0001
897 PRESYNCOPE 2 0.0001
898 LIVER INJURY 2 0.0001
899 PNEUMONIA ASPIRATION 2 0.0001
900 AGGRESSION 4 0.0001
901 DYSPNOEA EXERTIONAL 3 0.0001
902 HALLUCINATION 6 0.0001
903 ACNE 6 0.0001
904 PRODUCT COMPLAINT 2 0.0001
905 CARDIOVASCULAR DISORDER 2 0.0001
906 ERYTHEMA 16 0.0001
907 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0001
908 SUICIDAL IDEATION 7 0.0001
909 MUSCULOSKELETAL PAIN 4 0.0001
910 HYPERSENSITIVITY 14 0.0001
911 BREAST CANCER FEMALE 2 0.0001
912 THROMBOSIS 6 0.0001
913 EMOTIONAL DISTRESS 9 0.0001
914 BLOOD BILIRUBIN INCREASED 2 0.0001
915 NEUTROPHIL COUNT DECREASED 3 0.0001
916 MOOD ALTERED 2 0.0001
917 MIGRAINE 7 0.0001
918 LUNG NEOPLASM MALIGNANT 3 0.0001
919 OSTEOPOROSIS 3 0.0001
920 GASTROINTESTINAL HAEMORRHAGE 6 0.0001
921 TARDIVE DYSKINESIA 2 0.0001
922 PAIN IN JAW 2 0.0001
923 RHEUMATOID ARTHRITIS 8 0.0001
924 INTENTIONAL DOSE OMISSION 2 0.0001
925 EYE IRRITATION 4 0.0001
926 VAGINAL HAEMORRHAGE 3 0.0001
927 LIVER FUNCTION TEST ABNORMAL 2 0.0001
928 PRODUCT USE IN UNAPPROVED INDICATION 17 0.0001
929 PRODUCT STORAGE ERROR 6 0.0001
930 UNDERDOSE 5 0.0001
931 AGITATION 5 0.0001
932 ASCITES 2 0.0001
933 OESOPHAGEAL CARCINOMA 2 0.0001
934 RENAL INJURY 2 0.0001
935 COLITIS ULCERATIVE 3 0.0001
936 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
937 EPISTAXIS 5 0.0001
938 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
939 SKIN IRRITATION 3 0.0001
940 COGNITIVE DISORDER 3 0.0001
941 BONE DENSITY DECREASED 2 0.0001
942 DRUG-INDUCED LIVER INJURY 2 0.0001
943 RENAL CANCER 3 0.0001
944 PROSTATE CANCER 5 0.0001
945 DEVICE DIFFICULT TO USE 4 0.0001
946 SKIN DISORDER 2 0.0001
947 EYE PRURITUS 2 0.0001
948 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
949 ANGER 2 0.0001
950 FLUSHING 6 0.0001
951 NEUTROPENIA 8 0.0001
952 DELIRIUM 2 0.0001
953 NEOPLASM PROGRESSION 2 0.0001
954 HAEMORRHAGE 6 0.0001
955 SPEECH DISORDER 3 0.0001
956 LYMPHADENOPATHY 2 0.0001
957 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
958 SKIN BURNING SENSATION 4 0.0001
959 OVERDOSE 12 0.0001
960 WHITE BLOOD CELL COUNT DECREASED 6 0.0001
961 CRYING 2 0.0001
962 DEATH 47 0.0001
963 HAEMATOCHEZIA 3 0.0001
964 EYE SWELLING 2 0.0001
965 BREAST CANCER 5 0.0001
966 DYSARTHRIA 2 0.0001
967 PLASMA CELL MYELOMA 2 0.0001
968 DRUG DOSE OMISSION BY DEVICE 4 0.0001
969 WHEEZING 3 0.0001
970 ABNORMAL BEHAVIOUR 2 0.0001
971 ABORTION SPONTANEOUS 2 0.0000
972 NO ADVERSE EVENT 9 0.0000
973 ACCIDENTAL EXPOSURE TO PRODUCT 5 0.0000
974 EXPOSURE DURING PREGNANCY 3 0.0000
975 MATERNAL EXPOSURE DURING PREGNANCY 4 0.0000
976 ADVERSE DRUG REACTION 4 0.0000
977 ADVERSE EVENT 4 0.0000
978 DEVICE MALFUNCTION 3 0.0000
979 INJURY 3 0.0000
980 MULTIPLE SCLEROSIS 2 0.0000
981 INTERSTITIAL LUNG DISEASE 2 0.0000
982 LUNG DISORDER 2 0.0000
983 FLUID RETENTION 2 0.0000
984 TREATMENT FAILURE 3 0.0000
985 PRODUCT DOSE OMISSION 2 0.0000
986 HAEMOGLOBIN DECREASED 3 0.0000
987 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
988 UNEVALUABLE EVENT 2 0.0000
989 DISEASE PROGRESSION 3 0.0000
990 DRUG ABUSE 2 0.0000
991 TOXICITY TO VARIOUS AGENTS 4 0.0000
992 PULMONARY EMBOLISM 2 0.0000